NCT05245591View on ClinicalTrials.gov

Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2029

Conditions
Radiation Cystitis
Interventions
DRUG

Pentosan Polysulfate Sodium 100 MG Oral Capsule

Pentosan Polysulfate Sodium 100 mg three times daily (tid) for 0-8 weeks Pentosan Polysulfate Sodium 100 mg twice daily (bid) for 9-16 weeks

DRUG

Placebo

Placebo 100 mg three times daily (tid) for 0-8 weeks Placebo 100 mg twice daily (bid) for 9-16 weeks

Trial Locations (1)

Unknown

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

TCM Biotech International Corporation

UNKNOWN

lead

National Taiwan University Hospital

OTHER